Slideset
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, with topics including:
Presenters:
Jeremy S. Abramson, MD, MMSc
Associate Professor
Department of Medicine
Harvard Medical School
Director, Center for Lymphoma
Massachusetts General Hospital
Boston, Massachusetts
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Gain key clinical insights quickly with this short slideset from CCO on the use of PI3K inhibitors in the treatment of follicular lymphoma.
John M. Burke, MD
Nathan H. Fowler, MD
Released: June 18, 2021
Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on CAR T-cell therapy
Caron A. Jacobson, MD
Jae H. Park, MD
Noopur Raje, MD
Released: June 18, 2021
Podcast with Drs Suzanne Lentzsch and Saad Usmani answering questions on optimal management of relapsed/refractory multiple myeloma (R/R MM) from Clinical Care Options (CCO)
Suzanne Lentzsch, MD, PhD
Saad Z. Usmani, MD, MBA, FACP
Released: June 17, 2021
Key clinical insights from Drs Suzanne Lentzsch and Saad Usmani on individualizing care for patients with MM, from Clinical Care Options (CCO)
Suzanne Lentzsch, MD, PhD
Saad Z. Usmani, MD, MBA, FACP
Released: June 17, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.